Sort
39,280 grants matching “leukemia”
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
$633,462Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence
$633,402Elizabeth Bouchard · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Genomic biomarkers for cutaneous T-cell Lymphoma
$633,362Megan S. Lim · University Of Pennsylvania · R01 · FY2020 · CA
Activation of Proto-Oncogenes by Chromosomal Translocation
$633,018Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Collaborative Pathways that Lead to Leukemia
$633,018Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$633,018Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA
$632,757Nancy L Allbritton · University Of Washington · R01 · FY2022 · CA
Uncovering the role for MSI2 network in hematopoietic stem cells
$632,731Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2021 · DK
Uncovering the role for MSI2 network in hematopoietic stem cells
$632,731Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2023 · DK
Uncovering the role for MSI2 network in hematopoietic stem cells
$632,731Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2022 · DK
Uncovering the role for MSI2 network in hematopoietic stem cells
$632,731Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2020 · DK
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies
$632,637John C Byrd · University Of Cincinnati · UG1 · FY2024 · CA
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies
$632,637John C Byrd · University Of Cincinnati · UG1 · FY2025 · CA
Graft-versus-Host Disease: Local Maintenance in Target Tissues by Tissue Resident Memory-Type Cells.
$632,628Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$632,471Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
$632,461Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · DK
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA
$632,409Nancy L Allbritton · University Of Washington · R01 · FY2023 · CA
Retroviral Replication and Interactions with Host Factors
$632,394Vinay K. Pathak · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
$632,343Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2022 · AI
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
$632,343Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2020 · AI
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
$632,343Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2018 · AI
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
$632,343Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2019 · AI
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENT
$632,343Ellen V. Rothenberg · California Institute Of Technology · R01 · FY2021 · AI
Targeting B7-H3 in ovarian cancer
$632,310Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity
$632,159Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2025 · HL